CG Oncology, Inc. (CGON) stock
CGONNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$80.00+1.06 (+1.34%)
Close on Nov 18, 2026Market cap $7.09BP/E –Yield –
CG Oncology gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$1.07M | – |
| Q3 FY2025 | Sep 30, 2025 | $89.00K | – |
See a number that looks wrong?